AKT-IN-1 is an allosteric AKT inhibitor used for inhibiting AKT phosphorylation at both Thr308 and Ser473 in cells; it suppresses the phosphorylation of downstream effectors of the PI3K-AKT pathway, including ribosomal protein S6 and PRAS40; in vivo, it demonstrates potent inhibition of tumor growth in BT474c breast adenocarcinoma xenograft models in a dose-dependent manner upon oral administration, and significantly inhibits phosphorylation of GSK3β and AKT (Ser473) in tumor tissues.